Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

CorMedix Inc. (CRMD)

4.5625   0.083 (1.84%) 02-03 14:42
Open: 4.4 Pre. Close: 4.48
High: 4.62 Low: 4.4
Volume: 195,443 Market Cap: 188(M)

Technical analysis

as of: 2023-02-03 2:15:54 PM
Overall:       
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 5.53     One year: 6.46
Support: Support1: 4.02    Support2: 3.58
Resistance: Resistance1: 4.73    Resistance2: 5.53
Pivot: 4.37
Moving Average: MA(5): 4.41     MA(20): 4.39
MA(100): 3.67     MA(250): 3.98
MACD: MACD(12,26): 0     Signal(9): 0
Stochastic oscillator: %K(14,3): 74.9     %D(3): 65.1
RSI: RSI(14): 59.7
52-week: High: 8.02  Low: 2.65
Average Vol(K): 3-Month: 251 (K)  10-Days: 239 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ CRMD ] has closed below upper band by 21.1%. Bollinger Bands are 37% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 4.65 - 4.66 4.66 - 4.68
Low: 4.36 - 4.39 4.39 - 4.41
Close: 4.45 - 4.48 4.48 - 4.51

Company Description

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as hemodialysis, total parenteral nutrition, and oncology. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.

Headline News

Thu, 02 Feb 2023
Daraz appoints Talat Rahim as chief marketing officer - The Business Standard

Thu, 02 Feb 2023
Mercantile Bank holds CIB Online Reporting training - The Business Standard

Sat, 21 Jan 2023
How to Set Up a Company in Cyprus: The Ultimate Guide - Nomad Capitalist

Tue, 17 Jan 2023
CorMedix Inc. Announces Promotions in Commercial and Tech Ops - GlobeNewswire

Thu, 12 Jan 2023
ERE Healthcare Real Estate Advisors ('ERE') is Pleased to Announce the Successful Sale of a 34,090 SF Comprehensive Retina and Dialysis Portfolio in Central Florida - Yahoo Finance

Wed, 16 Nov 2022
Will CorMedix Inc. (CRMD) Outperform the Rest of the Stocks in the Healthcare Sector? - InvestorsObserver

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 0 (M)
Shares Float 41 (M)
% Held by Insiders 4.073e+007 (%)
% Held by Institutions 1.2 (%)
Shares Short 1,540 (K)
Shares Short P.Month 0 (K)

Stock Financials

EPS -2.993e+007
EPS Est Next Qtl -0.13
EPS Est This Year -0.53
EPS Est Next Year -0.29
Book Value (p.s.) 0
Profit Margin (%) 0
Operating Margin (%) -32
Return on Assets (ttm) 588.1
Return on Equity (ttm) -27.3
Qtrly Rev. Growth 92100
Gross Profit (p.s.) -34.94
Sales Per Share -19.84
EBITDA (p.s.) 17872.3
Qtrly Earnings Growth -0.8
Operating Cash Flow 0 (M)
Levered Free Cash Flow -24 (M)

Stock Valuations

PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales -0.23
Price to Cash Flow 7.75

Stock Dividends

Dividend 0
Forward Dividend 1.64e+006
Dividend Yield 0%
Dividend Pay Date 2019-03-25
Ex-Dividend Date Invalid DateTime.
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.